Market Overview

Morgan Stanley: 'Future Looks Bright' At Anthem

Share:
Related
New Aetna Clinical Policy Bulletin Details 'Medical Necessity' Of Sarepta's Exondys 51
Aetna Still Undecided On Coverage For Sarepta's Highly Debated Muscular Dystrophy Treatment
UnitedHealth, The Amazon Of Health Care, Isn't Sweating Trump (Investor's Business Daily)
Related HUM
Aetna Still Undecided On Coverage For Sarepta's Highly Debated Muscular Dystrophy Treatment
Watch These 3 Huge Put Purchases In Friday Trade
The 5 Best Stocks In Each Sector Since The Election (Seeking Alpha)

In a report published Thursday, Morgan Stanley analysts maintained an Equal-Weight rating on Anthem Inc (NYSE: ANTM), with a price target of $155, after the company reported its 1Q results significantly ahead of expectations.

Anthem reported its 1Q EPS at ~$0.50, ahead of consensus estimates, driven by commercial performance. The aggregate MLR declined 250bps Y/Y mainly on account of lower medical costs in the Local Group and individual businesses.

In the report Morgan Stanley noted, "Enrollment was also higher-than-expected in the quarter driven primarily by increases in self-funded membership."

Anthem raised its revenue and EPS outlook for FY15 to ~$78.5B and >$9.90, respectively. "Management also mentioned positive trends into 2016 including an expectation for improved Medicare performance, two large National Account wins, and lower ACA headwinds," the analysts said, while adding that the outlook revision looks "conservative to us."

The EPS and revenue estimates for 2015 have been raised to $10.10 and ~$78.5, respectively, after after the strong start to the year and to reflect higher self-funded membership. The EPS estimate for 2016 has been raised to $11.30.

The analysts believe that the issues highlighted by Humana Inc
(NYSE: HUM) are company-specific and should not impact Anthem.

Latest Ratings for ANTM

DateFirmActionFromTo
Nov 2016Wolfe ResearchUpgradesPeer PerformOutperform
Nov 2016Wells FargoUpgradesMarket PerformOutperform
Oct 2016JP MorganDowngradesOverweightNeutral

View More Analyst Ratings for ANTM
View the Latest Analyst Ratings

Posted-In: Morgan Stanley VetrAnalyst Color Reiteration Analyst Ratings

 

Related Articles (HUM + ANTM)

View Comments and Join the Discussion!